×
About 3,728 results

ALLMedicine™ Optic Neuritis Center

Research & Reviews  1,156 results

Neuro-inflammatory disease following SARS-CoV-2 infection in children.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106400
The Journal of Pediatrics; Aubart M, Roux CJ et. al.

May 17th, 2022 - To describe neurologic, radiologic and laboratory features in children with central nervous system (CNS) inflammatory disease complicating SARS-CoV-2 infection. We focused on CNS inflammatory diseases in children referred from 12 hospitals in the ...

The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders
https://clinicaltrials.gov/ct2/show/NCT01623076

May 11th, 2022 - This study seeks to determine the biologic causes of inflammation in patients with Neuromyelitis Optica (NMO), Transverse Myelitis (TM), optic neuritis (ON), related conditions and healthy controls. While patients will be treated according to deci...

Myelin oligodendrocyte glycoprotein antibody-associated bilateral optic neuritis with u...
https://doi.org/10.1016/j.jaapos.2022.02.007
Journal of AAPOS : the Official Publication of the Americ... Mudri J, Warne R et. al.

May 8th, 2022 - We present a case of bilateral myelin oligodendrocyte glycoprotein antibody optic neuritis (MOG-ON) with unilateral vitreous hemorrhage in a 6-year-old boy. Multidisciplinary team care, including extensive investigations and prolonged follow-up, e...

Optic neuritis with potential for poor outcome.
https://doi.org/10.1136/practneurol-2021-003228
Practical Neurology; Cooper SA, Leddy SG et. al.

May 3rd, 2022 - The Optic Neuritis Treatment Trial previously reported that corticosteroids accelerated visual recovery in optic neuritis (ON) without improving outcome. This finding related largely to multiple sclerosis (MS), and subsequently neurologists tended...

Systemic Lupus Erythematous and Neuromyelitis Optica Causing Hypercapnic Respiratory Fa...
https://doi.org/10.12659/AJCR.936283
The American Journal of Case Reports; Dominguez B, Koilpillai S et. al.

May 2nd, 2022 - BACKGROUND Neuromyelitis optica (NMO) is a rare neurological disease characterized by attacks of transverse myelitis and optic neuritis, contiguous spinal cord lesions on more than 3 vertebral segments on magnetic resonance imaging (MRI), and sero...

see more →

Guidelines  1 results

EULAR recommendations for the management of systemic lupus erythematosus with neuropsyc...
https://doi.org/10.1136/ard.2010.130476
Annals of the Rheumatic Diseases; Bertsias GK, Ioannidis JP et. al.

Aug 21st, 2010 - To develop recommendations for the diagnosis, prevention and treatment of neuropsychiatric systemic lupus erythematosus (NPSLE) manifestations. The authors compiled questions on prevalence and risk factors, diagnosis and monitoring, therapy and pr...

see more →

Drugs  171 results see all →

Clinicaltrials.gov  36 results

The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders
https://clinicaltrials.gov/ct2/show/NCT01623076

May 11th, 2022 - This study seeks to determine the biologic causes of inflammation in patients with Neuromyelitis Optica (NMO), Transverse Myelitis (TM), optic neuritis (ON), related conditions and healthy controls. While patients will be treated according to deci...

Expression of PARP-1 in Multiple Sclerosis Patients
https://clinicaltrials.gov/ct2/show/NCT05196425

Jan 19th, 2022 - This study will explore the expression of PARP-1 in optic neuritis of multiple sclerosis patients. The data will be collected from Sohag University hospital in the period from the start of August 2021 to the end of December 2021. The study protoco...

Effectiveness of Plasma Exchange in Treating With Severe Acute AQP4-Ab Positive Optic Neuritis
https://clinicaltrials.gov/ct2/show/NCT03586557

Aug 17th, 2021 - Definition: This will be a parallel designed, open-labeled, randomized add-on comparison study between 1) intravenous high dose corticosteroids combined with plasma exchange (PE) and 2) merely intravenous high dose corticosteroids followed subsequ...

Visual Reconstitution Therapy After Optic Neuritis
https://clinicaltrials.gov/ct2/show/NCT01274702

Jul 29th, 2021 - Patients with an acute optic neuritis (between 60 and 180 days before screening) or with residual visual deficits after a past optic neuritis are randomized in two treatment groups. Group A is instructed to perform software-based visual reconstitu...

Optical Coherence Tomography and Optic Neuritis (OCTON)
https://clinicaltrials.gov/ct2/show/NCT02573792

Jun 22nd, 2021 - Optic neuritis (ON) can remain isolated or reveal a widespread and chronic disease of the central nervous system (CNS), a multiple sclerosis (MS) or, more rarely, a Devic's neuromyelitis optica (NMO) or a systemic disease. The optical coherence to...

see more →

News  122 results

Vision-Threatening Retinal Condition Linked to COVID-19
https://www.medpagetoday.com/ophthalmology/generalophthalmology/98212

Apr 14th, 2022 - COVID-19 infection may be boosting the numbers of a rare ocular condition in which vision is threatened when veins in the retina are blocked, eye specialists in Southern California report. Risk of retinal vein occlusion was higher in the 6 months ...

Erythropoietin Falls Short of Neuroprotection in Optic Neuritis
https://www.medscape.com/viewarticle/946851

Mar 4th, 2021 - Erythropoietin (EPO), shown in early studies to potentially provide neuroprotection for patients with optic neuritis, failed to provide any significant neuroprotection in comparison with placebo in a phase 3 randomized controlled trial. "EPO conve...

Newer DMTs More Effective vs Injectables in Pediatric MS
https://www.medscape.com/viewarticle/939952

Oct 28th, 2020 - Among patients with pediatric-onset relapsing-remitting multiple sclerosis (MS), newer disease-modifying therapies (DMTs) reduce clinical and radiological disease activity more effectively than older injectable therapies. Nevertheless, all DMTs re...

New Developments, Challenges in Treating NMOSD
https://www.staging.medscape.com/viewarticle/939569

Oct 22nd, 2020 - New developments in treatment of neuromyelitis optica spectrum disorder (NMOSD) have opened up options for disease treatment in pediatric patients, but have led to some uncertainty and confusion as well. At the2020 CNS-ICNA Conjoint Meeting, held ...

New Developments, Challenges in Treating NMOSD
https://www.medscape.com/viewarticle/939569

Oct 22nd, 2020 - New developments in treatment of neuromyelitis optica spectrum disorder (NMOSD) have opened up options for disease treatment in pediatric patients, but have led to some uncertainty and confusion as well. At the2020 CNS-ICNA Conjoint Meeting, held ...

see more →

Patient Education  5 results see all →